2010
DOI: 10.1248/bpb.33.1932
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical Characterization of Epigallocatechin-3-gallate as an Effective Stimulator for the Phosphorylation of Its Binding Proteins by Glycogen Synthase Kinase-3&beta; <i>in Vitro</i>

Abstract: Glycogen synthase kinase 3 (GSK-3) is a constitutively active, proline-directed serine (Ser)/threonine (Thr) protein kinase encoded by two isoforms and GSK-3b (approx. 47 kDa)], which possess similar biochemical characteristics and substrate specificities.1-3) GSK-3 has been originally identified as a protein kinase that phosphorylates the rate-limiting enzyme, glycogen synthase (GS), in glycogen synthesis. 4,5) Further detail characterization revealed that (i) GSK-3b has a wide array of substrates, including… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…Although there are no reports of the mechanism of action of quercetin regarding tauopathy, it has been found that epigallocatechin-3-gallate (EGCG), a potent antioxidant structurally related to quercetin, induced a reduction in potentially toxic sarkosyl-soluble phospho-tau isoforms (Rezai-Zadeh et al, 2008). Additionally, EGCG-inducible phosphorylation sites on GSK-3β have been demonstrated in vitro (Miyai et al, 2010). This mechanism has been recognized to underlie the Morin-flavonoid-induced reduction of tau hyperphosphorylation (Gong et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Although there are no reports of the mechanism of action of quercetin regarding tauopathy, it has been found that epigallocatechin-3-gallate (EGCG), a potent antioxidant structurally related to quercetin, induced a reduction in potentially toxic sarkosyl-soluble phospho-tau isoforms (Rezai-Zadeh et al, 2008). Additionally, EGCG-inducible phosphorylation sites on GSK-3β have been demonstrated in vitro (Miyai et al, 2010). This mechanism has been recognized to underlie the Morin-flavonoid-induced reduction of tau hyperphosphorylation (Gong et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…In fact, GSK-3b is signicantly involved in key pathological events, namely Tau hyperphosphorylation, amyloidogenesis, inammatory response and ACh decit. 55 As the modulation of GSK-3b activity was also mediated by a diversity of polyphenolic systems [56][57][58] it was decided to screen HCAs and derivatives (compounds 1, 2 and 7-14) towards GSK-3b, at a xed concentration of 10 mM, using a previously described luminescent technique. Recent studies report the ability of compound 1 and its natural phenethyl ester derivative (CAPE) to modulate the Akt/GSK-3b signalling pathway and GSK-3b activity.…”
Section: Gsk-3b Inhibitory Activitymentioning
confidence: 99%
“…2) From these previous reports, 1,2) we conclude that both EGCG and SH may function as effective stimulators for the GSK-3β-mediated phosphorylation of these two basic brain proteins (bMBP and rhTP), containing multiple potent phosphorylation sites for the kinase in vitro. 1,2) Glycogen synthase kinase 3 (GSK-3) is a constitutively active, proline-directed serine (Ser)/threonine (Thr) protein kinase encoded by two isoforms [GSK-3α (approx.…”
mentioning
confidence: 61%
“…EGCG had binding affinities with these two basic proteins, as previously reported. 1) However, the binding abilities of these three Taxus compounds with three protein substrates (bMBP, rhTP and rCRMP-2) did …”
Section: The Stimulatory Effects Of Three Taxus Compounds On the Automentioning
confidence: 94%
See 1 more Smart Citation